Stocks and Investing Stocks and Investing
Tue, May 24, 2016
Mon, May 23, 2016
Fri, May 20, 2016
Thu, May 19, 2016

Keay Nakae Initiated (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016


Published on 2024-10-25 17:03:41 - WOPRAI, Keay Nakae
  Print publication without navigation


Keay Nakae of Chardan Capital, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016.

Keay, nor any peers, have made any analyst calls on ARWR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources